These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9280118)

  • 21. Ginsenoside Rd induces protective anti-Candida albicans antibody through immunological adjuvant activity.
    Han Y; Rhew KY
    Int Immunopharmacol; 2013 Nov; 17(3):651-7. PubMed ID: 24007781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections.
    Fidel PL; Cutright JL; Sobel JD
    Infect Immun; 1995 Oct; 63(10):4191-4. PubMed ID: 7558342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate immune cell response upon Candida albicans infection.
    Qin Y; Zhang L; Xu Z; Zhang J; Jiang YY; Cao Y; Yan T
    Virulence; 2016 Jul; 7(5):512-26. PubMed ID: 27078171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the intranasal challenge route in mice as a mucosal model for Candida albicans infection.
    Londono P; Gao XM; Bowe F; McPheat WL; Booth G; Dougan G
    Microbiology (Reading); 1998 Aug; 144 ( Pt 8)():2291-2298. PubMed ID: 9720052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of the immune response suppression in mice inoculated with Candida albicans.
    Valdez JC; Mesón DE; Sirena A; de Petrino SF; Eugenia M; de Jorrat BB; de Valdex MG
    Mycopathologia; 1986 Mar; 93(3):147-50. PubMed ID: 3520329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effects of a protein-bound polysaccharide, PSK, against Candida albicans infection in syngeneic tumor-bearing mice via Th1 cell functions.
    Ohmura Y; Matsunaga K; Motokawa I; Sakurai K; Ando T
    Cancer Biother Radiopharm; 2003 Oct; 18(5):769-80. PubMed ID: 14629825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Animal models for candidiasis.
    Romani L
    Curr Protoc Immunol; 2001 May; Chapter 19():Unit 19.6. PubMed ID: 18432757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ginsenoside Rg1 helps mice resist to disseminated candidiasis by Th1 type differentiation of CD4+ T cell.
    Lee JH; Han Y
    Int Immunopharmacol; 2006 Sep; 6(9):1424-30. PubMed ID: 16846836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of immunosuppressive effects of cyclosporine A in a murine model of systemic candidiasis and of localized thrushlike lesions.
    Krause MW; Schaffner A
    Infect Immun; 1989 Nov; 57(11):3472-8. PubMed ID: 2807532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CpG oligodeoxynucleotides increase the susceptibility of normal mice to infection by Candida albicans.
    Ito S; Pedras-Vasconcelos J; Klinman DM
    Infect Immun; 2005 Sep; 73(9):6154-6. PubMed ID: 16113339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of adaptive immunity in the pathogenesis of Candida albicans keratitis.
    Zhang H; Chen H; Niu J; Wang Y; Xie L
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2653-9. PubMed ID: 19218608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deltamethrin Increases Candida albicans infection susceptibility in mice.
    Rehman H; Mohan A; Tabassum H; Ahmad F; Rahman S; Parvez S; Raisuddin S
    Scand J Immunol; 2011 May; 73(5):459-64. PubMed ID: 21272049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulation by Candida albicans: crucial role of organ colonization and chronic infection with an attenuated agerminative strain of C. albicans for establishment of anti-infectious protection.
    Vecchiarelli A; Mazzolla R; Farinelli S; Cassone A; Bistoni F
    J Gen Microbiol; 1988 Sep; 134(9):2583-92. PubMed ID: 3076189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of Candida albicans infection on the immunological response in mice].
    Jakoniuk P; Jablońska W; Borowski J
    Gruzlica; 1972; 40(12):1139-45. PubMed ID: 4567377
    [No Abstract]   [Full Text] [Related]  

  • 35. [The comparative characteristics of the effect of immunomodulators on the indices of body nonspecific protection and on the structure of the populations of the causative agents in mixed infections].
    Shatalova EV; Bel'skiĭ VV; Elinov NP
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (1):54-8. PubMed ID: 9221659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of pseudohyphal growth as a neutrophil-mediated host defense mechanism against experimental deep Candida albicans infections in mice.
    Sohnle PG; Hahn BL
    J Lab Clin Med; 1993 Feb; 121(2):235-43. PubMed ID: 8433039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice.
    Kullberg BJ; van 't Wout JW; Hoogstraten C; van Furth R
    J Infect Dis; 1993 Aug; 168(2):436-43. PubMed ID: 8335982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance and susceptibility to infection in inbred murine strains. I. Variations in the response to thymic hormones in mice infected with Candida albicans.
    Salvin SB; Neta R
    Cell Immunol; 1983 Jan; 75(1):160-72. PubMed ID: 6218893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cyclophosphamide on the course of Candida albicans infection in normal and vaccinated mice.
    Japoni A; Mehrabani D; Alborzi A; Farshad S; Hayati M; Dehyadegari MA
    Saudi Med J; 2006 Jan; 27(1):46-51. PubMed ID: 16432593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influences of immunosuppressive agents, FK506 and cyclosporin on systemic Candida albicans infection in mice.
    Ito E; Tanaka Y
    Mycopathologia; 1997; 138(2):57-64. PubMed ID: 9433807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.